ZHONGZHIPHARM (03737) has announced that it expects the net profit for the full year ending December 31, 2025, to decrease by no less than 70% compared to the net profit for the full year ending December 31, 2024. In 2025, affected by industry policy adjustments leading to a short-term decline in sales revenue, the Group's profits have been impacted to a certain extent; nevertheless, the Group will maintain its market investment efforts and actively explore new business growth opportunities.